SMS Pharmaceuticals vs Peers
- Market cap
- ₹4,213 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹323.89 – ₹607.30
SMS Pharmaceuticals ranks 1st by market capitalisation among 1 Drug Manufacturers - General companies tracked by ATS. Its largest peers are SMS Pharmaceuticals. Its P/E of 22.5 compares with a peer median of 22.5.
SMS Pharmaceuticals vs Drug Manufacturers - General peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals | 449.85 | +0.69% | 4,213 | 22.5 | 2.85 | 14.5% | +18.5% |
| SMS Pharmaceuticals | 449.85 | +0.69% | 4,213 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
SMS Pharmaceuticals peer comparison — frequently asked questions
Who are SMS Pharmaceuticals' competitors?
SMS Pharmaceuticals' listed peers in Drug Manufacturers - General include SMS Pharmaceuticals, ranked here by market capitalisation.
How does SMS Pharmaceuticals' P/E compare with its peers?
SMS Pharmaceuticals trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - General peers shown.
Which is the largest company among SMS Pharmaceuticals' peers?
By market capitalisation, the largest company in the group is SMS Pharmaceuticals at ₹4,213 crore, against ₹4,213 crore for SMS Pharmaceuticals.
Same Data For Peers
- Solara Active Pharma Sciences Limited peer comparison
- Shilpa Medicare Limited peer comparison
- Sun Pharma Advanced Research Company Limited peer comparison
- Senores Pharmaceuticals Limited peer comparison
- Strides Pharma Science Limited peer comparison
- Sanofi Consumer Healthcare India Limited peer comparison
Trade SMS Pharmaceuticals With ATS
Track SMSPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.